SBC Medical shares surge 14.88% premarket after announcing tender offer to acquire Waqoo, aiming to boost R&D and integrate technologies.

SBC Medical Group Holdings surged 14.88% in premarket trading following the announcement of a tender offer to acquire shares of Waqoo, Inc. The Japanese subsidiary of SBC will purchase up to 575,000 shares at JPY 1,900 per share, with the goal of consolidating Waqoo into its operations. The transaction, including a related-party share transfer by CEO Yoshiyuki Aikawa, aims to integrate Waqoo’s research capabilities into SBC’s clinical services, enhancing competitiveness in AGA, orthopedics, and regenerative medicine. The strategic move signals expanded R&D and technological synergy, aligning with SBC’s global expansion goals and triggering investor optimism.